4.65 DESTINY BREAST 04 - A complex trial to deconstruct
Jun 07, 2022•32 min
Episode description
My take on the standing ovation for DESTINY Breast 04
Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast